MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-20-0006044
Innova Pharmactive Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹19.04 Cr
▲ 5% YoY
Net profit · FY 2025
₹1.31 Cr
Net margin 6.9%
EBITDA · FY 2025
₹2.66 Cr
EBITDA margin 14%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.53 Cr
Issued & subscribed
Open charges
₹4.2 Cr
Satisfied ₹2.1 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
24
Provident fund records
About Innova Pharmactive Private Limited
Data last updated:
Innova Pharmactive Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 22 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC204654. Its GSTIN is 27AACCI3571K1ZD (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.53 Cr. It is led by directors including Umang Rajesh Khandelwal (Whole-Time Director) and Sulabh Prakash Khandelwal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ns 13 To 16 Nagpur Industrial Estate Co.Op. Society Ltd. Uppalwadi, Maharashtra, India – 440026.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.04 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.31 Cr (net margin 6.9%) and EBITDA of ₹2.66 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 9% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Innova Pharmactive. As per MCA filings, the company has open charges of ₹4.2 Cr and satisfied charges of ₹2.1 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.
Innova Pharmactive Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0006044). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovapharmactive.com.
Company details
CIN U24100MH2010PTC204654
Registration Number 204654
Incorporation Date 22 June 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-20-0006044
Key People
Umang Rajesh Khandelwal Whole-Time Director Sulabh Prakash Khandelwal Whole-Time Director Amit Umeshchand Khandelwal Whole-Time Director Recognitions & Rankings of Innova Pharmactive
Contact details
Innova Pharmactive Private Limited's registered office is in Nagpur, Maharashtra. Its website is innovapharmactive.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNs 13 To 16 Nagpur Industrial Estate Co.Op. Society Ltd. Uppalwadi, Maharashtra, India – 440026
- IndustryPharma, API Manufacturers
To see the full contact details of Innova Pharmactive Private Limited, buy the company report.
Comprehensive company report
Innova Pharmactive Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Innova Pharmactive operates one associated brand: Innova Pharmactive. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets Active Pharmaceutical Ingredients for global pharmaceutical firms. | innovapharmactive.com |
Business activity
The main business activity of Innova Pharmactive is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Innova Pharmactive Private Limited, buy the company report.
Financials of Innova Pharmactive Private Limited
FY 2025 filings availableInnova Pharmactive Private Limited reported revenue of ₹19.04 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹19.04 Cr ▲ 5%
Net profit · FY 2025
₹1.31 Cr margin 6.9%
EBITDA · FY 2025
₹2.66 Cr margin 14%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 16%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▲ 8%
5 years · compounded
▲ 7%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 5% growth in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.31 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | ||||
| Net Profit Margin | 6.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innova Pharmactive Private Limited, buy the company report.
Board of directors of Innova Pharmactive Private Limited
Innova Pharmactive has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umang Rajesh Khandelwal | Whole-Time Director | 03 Sep 2022 | 4 Years 1 Months | Current |
| Sulabh Prakash Khandelwal Also directs: Innova Remedies Private Limited | Whole-Time Director | 29 Jun 2012 | 14 Years 3 Months | Current |
| Amit Umeshchand Khandelwal Also directs: Innova Remedies Private Limited | Whole-Time Director | 22 Jun 2010 | 16 Years 4 Months | Current |
| Rakesh Motilal Khandelwal | Whole-Time Director | 22 Jun 2010 | 16 Years 4 Months | Current |
Peer comparison
Innova Pharmactive Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vihita Bio-Chem Private Limited | ₹19.24 Cr (FY 2025) | 30.0% | Bharuch, Gujarat, India | |||
| Great Pacific Exports Private Limited | ₹19.22 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Padarsh Pharmaceuticals Private Limited | ₹19.21 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Innova Pharmactive Private Limitedthis company | ₹19.04 Cr (FY 2025) | ₹1.31 Cr | 6.9% | 5.0% | 24 | Nagpur, Maharashtra, India |
| Karvy Therapeutics Pvt Ltd | ₹18.98 Cr (FY 2025) | 51.0% | Haripar Pal, Gujarat, India | |||
| Cennet Biopharma Private Limited | ₹18.59 Cr (FY 2024) | 27.0% | Delhi, India | |||
| Anamayee Pharmachem Private Limited | ₹18.45 Cr (FY 2015) | -33.0% | Goa, India |
To see the full peer comparison of Innova Pharmactive Private Limited, buy the company report.
Auditor
Innova Pharmactive Private Limited is audited by GUPTA SARDA & BAGDIA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA SARDA & BAGDIA | FY 2023 | 103447W |
Shareholding
The shareholding of Innova Pharmactive Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innova Pharmactive Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.2 Cr
Satisfied charges
₹2.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jul 2023 | 100749432 | Sidbi | ₹60 Lakh | Open | |
| 23 Oct 2013 | 10457122 | Others | ₹1.8 Cr | Open | |
| 10 Oct 2011 | 10312580 | Others | ₹1.8 Cr | Open | |
| 12 Mar 2020 | 100328902 | Sidbi | ₹1 Cr | Satisfied | |
| 20 Mar 2012 | 10342720 | Sidbi | ₹1.1 Cr | Satisfied |
To see the full charge records of Innova Pharmactive Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Innova Pharmactive Private Limited has 3 court cases on record: 1 filed by Innova Pharmactive, 2 filed against it. All cases are disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CHS) | Filed against the company by an individual | Disposed |
| Bombay High Court | Arbitration matter | Filed against the company by an individual | Disposed |
| District court, Nagpur, Maharashtra | Civil suit | Filed by the company against Ms Kieon Develpers Pvt.Ltd. and Other | Disposed |
To see the full case history of Innova Pharmactive Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Innova Pharmactive Private Limited has 6 MSME Form 1 returns on record between 2019 and 2022, listing 27 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aditya Air Products Private Limited | |||
| Riaan Diagnostic Private Limited | |||
| Vishvakariya Automotive Private Limited | |||
| Airbox Concepts Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Innova Pharmactive Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Innova Pharmactive Private Limited has a workforce of 24 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
GST
Innova Pharmactive has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCI3571K1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Innova Pharmactive Private Limited, buy the company report.
Recent activity
Innova Pharmactive Private Limited has 6 board changes on record since 2010: 5 appointments and 1 cessation. The latest: Umang Rajesh Khandelwal was appointed as Whole-Time Director on 03 Sep 2022.
AGM
Innova Pharmactive Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Innova Pharmactive Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 12 Mar 2020 via Charge ID 100328902 with Sidbi was fully satisfied on 21 Jul 2023.
Charges
A charge registered on 20 Mar 2012 via Charge ID 10342720 with Sidbi was fully satisfied on 21 Jul 2023.
Charges
A charge with Sidbi amounted to Rs. 0.60 Cr with Charge ID 100749432 was registered on 20 Jul 2023.
Appointed
Umang Rajesh Khandelwal was appointed as Whole-Time Director.
Charges
A charge with Sidbi of Rs. 1.10 Cr registered on 20 Mar 2012 with Charge ID 10342720 was modified on 26 Oct 2020.
Charges
A charge with Sidbi amounted to Rs. 1.00 Cr with Charge ID 100328902 was registered on 12 Mar 2020.
Charges
A charge with Others of Rs. 1.80 Cr registered on 23 Oct 2013 with Charge ID 10457122 was modified on 25 Jan 2018.
Charges
A charge with Others of Rs. 1.80 Cr registered on 10 Oct 2011 with Charge ID 10312580 was modified on 09 Jan 2018.
Ceased
Seema Rajesh Khandelwal ceased to be Whole-Time Director.
Charges
A charge with Others amounted to Rs. 1.80 Cr with Charge ID 10457122 was registered on 23 Oct 2013.
7 earlier events are in the company report.
Frequently asked questions
Innova Pharmactive is an active private limited company based in Nagpur, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 22 June 2010 (16+ years old) and is registered under CIN U24100MH2010PTC204654.
Innova Pharmactive has 4 current directors:
- Umang Rajesh Khandelwal - Whole-Time Director
- Sulabh Prakash Khandelwal - Whole-Time Director
- Amit Umeshchand Khandelwal - Whole-Time Director
- Rakesh Motilal Khandelwal - Whole-Time Director
The latest financial statements of Innova Pharmactive on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Innova Pharmactive is 27AACCI3571K1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Innova Pharmactive is U24100MH2010PTC204654. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innova Pharmactive has 3 court cases on record: 1 filed by the company and 2 filed against it. Most are in the high courts.
Innova Pharmactive was incorporated on 22 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Innova Pharmactive by revenue are Vihita Bio-Chem Private Limited, Great Pacific Exports Private Limited, Padarsh Pharmaceuticals Private Limited, Karvy Therapeutics Pvt Ltd, Cennet Biopharma Private Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Umang Rajesh Khandelwal was appointed as Whole-Time Director on 03 Sep 2022. Seema Rajesh Khandelwal ceased to be Whole-Time Director on 15 Jul 2015. Sulabh Prakash Khandelwal was appointed as Whole-Time Director on 29 Jun 2012. Innova Pharmactive has 6 board changes on record in total.
Yes, Innova Pharmactive is registered as a small enterprise under Udyam registration (number: UDYAM-MH-20-0006044).
Innova Pharmactive has 6 MSME Form 1 returns on record between 2019 and 2022, listing 27 overdue payments to 11 micro and small suppliers. The latest return was filed on 25 Sep 2023.
Innova Pharmactive can be reached through the website innovapharmactive.com. Its registered office is in Nagpur, Maharashtra, India.